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Abstract
Fear-potentiated startle (FPS) and prepulse inhibition (PPI) of acoustic startle are two widely used 
paradigms specifically designed to capture the impact of negative emotion (e.g. fear) and 
preattentive function on startle response. Currently, there is no single paradigm that incorporates 
both FPS and PPI, making it impossible to examine the potential interactions between fear and 
attention in the regulation of startle response. In this study, we developed an integrated FPS and 
PPI test protocol and validated it with psychoactive drugs. In Experiment 1, male Sprague-Dawley 
rats were randomly assigned to one of five groups, receiving either Light -Shock conditioning 
trials, non-overlapping Lights and Shocks, Light alone, Shock alone, or no Light and Shock. They 
were then tested for startle response and PPI concurrently, under the Light or No Light. FPS was 
observed only in rats subjected to fear conditioning, whereas all rats showed PPI and startle 
habituation. Experiment 2 used this paradigm and demonstrated a dissociative effect between 
diazepam (an anxiolytic drug) and phencyclidine (a nonselective NMDA receptor antagonist) on 
FPS and PPI. Diazepam suppressed both FPS and PPI, while PCP selectively disrupted PPI but not 
FPS. The diazepam’s anxiolytic effect on FPS was further confirmed in the elevated plus maze 
test. Together, our findings indicate that our paradigm combines FPS and PPI into a single 
paradigm, and that is useful to examine potential interactions between multiple psychological 
processes, to identify the common neural substrates and to screen new drugs with multiple 
psychoactive effects.
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1. Introduction
The startle response is an innate motoric response to a sudden and intense stimulus. It 
protects the integrity of the body and facilitates escape from potential danger. Startle can be 
elicited by acoustic, tactile and visual stimuli in a variety of animal species and in humans, 
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although the most commonly investigated phenomenon is acoustic startle response. Because 
the startle response magnitude can be modulated by a variety of psychological variables, 
such as fear, anxiety, learning, memory and attention, it becomes a valuable behavioral tool 
to assess neurobiological mechanisms of psychological functions. Fear-potentiated startle 
(FPS) and prepulse inhibition (PPI) are two exemplar paradigms that serve this purpose [1].
Fear-potentiated startle refers to a phenomenon that the magnitude of the acoustic startle 
reflex is augmented in the presence of a cue (e.g., a light) that has previously been paired 
with a shock [2]. In the test, a neutral stimulus (termed conditioned stimulus, CS) is first 
paired with a shock, and then the animal’s startle reflex is compared in either the presence or 
the absence of the CS. FPS is operationally defined by elevated startle amplitude in the 
presence of the CS and is supposed to measure a central state of fear. This paradigm is thus 
often used to study the neurobiology of conditioned fear and for the identification of 
potential anxiolytic drugs [3]. For example, using FPS, Davis and his colleagues suggested 
that the central and basolateral amygdala play a critical role in the mediation of fear learning 
and memory, as lesions of the central, or the basolateral nucleus of the amygdala block the 
impacts of conditioned fear on the startle response [4]. Psychopharmacological studies 
document that anxiolytic drugs that reduce overall excitability of the CNS, such as ethanol 
or diazepam, but not other classes of psychoactive drugs, have a common effect of 
attenuating the CS-elicited enhancement of startle response and having no effect on the 
baseline startle magnitude [4–7]. This feature has been used to identify potential anxiolytic 
drugs.
PPI is developed to study the sensorimotor gating ability, a preattentive process that is 
involved in early stages of information filtering [8]. PPI is observed when the amplitude of 
startle reflex elicited by an intense startling stimulus (e.g., 120 dB white noise) is reduced 
when the startle stimulus is immediately preceded by a weak prepulse (e.g. 80 dB white 
noise). PPI has often been used to study attention deficits associated with severe mental 
disorders such as schizophrenia and to screen potential antipsychotic drugs. For example, it 
has been widely used as a translational model of schizophrenia [9, 10], as animals treated 
with psychotomimetic drugs, such as amphetamine (a potent psychostimulant targeting 
monoamine transporters), quinpirole (a D2/3 agonist), PCP (a nonselective NMDA 
antagonist) or MK-801 (a nonselective NMDA antagonist) also exhibit PPI deficits [11–15]. 
Further, it has also been successfully used to screen chemical compounds with potential 
antipsychotic activity [16, 17], to rank order clinical potency of approved antipsychotics [9], 
and to differentiate atypical from typical antipsychotics [18].
Because each paradigm serves relatively independent purposes, FPS and PPI are often used 
separately. To the best of our knowledge, there is no paradigm that incorporates the fear-
potentiated component with the PPI component. However, such a combined paradigm would 
have some advantages. For example, it would allow an examination of interactive effects of 
fear and attention on the regulation of startle response, while a single paradigm is unable to 
do. Furthermore, the integrated paradigm is useful for identifying the shared neural 
substrates underlying conditioned fear (as measured in FPS) and attentional filtering ability 
(as measured in PPI). For instance, lesions of the basolateral amygdala is found to disrupt 
FPS and PPI in separate tests [4, 19]. The new paradigm would be able to corroborate this 
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finding in a single test. Finally, such an integrated paradigm would be efficiently used to 
identify novel compounds possessing dual anxiolytic and antipsychotic property in a single 
test. It also better serves as a behavioral model of severe mental disorders because most 
disorders have abnormal functions in multiple domains. In the present study, we report 
development of an integrated FPS and PPI test protocol by demonstrating the effectiveness 
of this paradigm in recording conditioned fear and sensorimotor gating ability 
simultaneously. In addition, we provide pharmacological validation showing that two 
psychoactive drugs (PCP and diazepam) maintain their selective and dissociative effects on 
FPS and PPI.
2. Materials and Methods
2.1 Subjects
Male adult Sprague-Dawley rats (~ 2–3 months old, Charles River, Portage, MI) were 
housed two per cage (30.48 cm × 29.21 cm × 17.78 cm), with food and water available ad 
libitum. The colony was under a 12/12h light/k cycle (lights on from 7:00 am to 7:00 pm), 
with temperature maintained at 22±1° and humidity around 32%. Experiments were 
conducted during the light portion of the cycle. All procedures were approved by the animal 
care committees at the University of Nebraska-Lincoln.
2.2 Startle and elevated plus maze apparatus
Six startle monitor systems (Kinder Scientific, Julian, CA) controlled by a PC were used. 
They were housed in compact sound attenuation cabinets (35.56 cm wide × 27.62 cm deep × 
49.53 cm high). A speaker (diameter: 11 cm) mounted on the cabinet’s ceiling was used to 
generate acoustic stimuli. During tests, rats were placed in a restrainer (17.2 cm long × 9.0 
cm wide) with an adjustable ceiling positioned atop the box, providing only limited restraint 
while prohibiting ambulation. The startle response was measured by a piezoelectric sensing 
platform on the floor in a time window of 100 ms, beginning at the onset of the startle-
eliciting stimulus (pulse). The peak value within the record window indexes the magnitude 
of the startle response. The CS (light) was delivered by an E light Bulb (18V, 6W, Eiko 
40717) mounted on the cabinet’s ceiling.
The EPM consisted of two open arms (50 cm × 10 cm), two enclosed arms (50 cm × 10 cm) 
and a central platform (10 cm × 10 cm) made of black Plexiglas. Each arm was supported by 
a sturdy plastic leg and was elevated 70 cm above the floor. The two enclosed arms had high 
walls (40 cm in height), while the two open arms had raised edges (1.0 cm in height) along 
each side and end to decrease the possibility of falling during drug testing.
2.3 Drugs
Diazepam (Sigma-Aldrich, St. Louis, MO) was dissolved in 30% N,N-Dimethylformamide 
(DMF, Sigma-Aldrich). Phencyclidine hydrochloride (PCP, a gift from NIDA Chemical 
Synthesis and Drug Supply Program [RTI, Research Triangle Park, NC]) was dissolved in 
0.9% saline. Diazepam was injected subcutaneously (s.c.) and PCP intraperitoneally (i.p.).
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2.4 Experiment 1: Behavioral validation of an integrated fear-potentiated startle and 
prepulse inhibition paradigm
Experiment 1 systematically evaluated the effectiveness of the integrated FPS and PPI 
paradigm to simultaneously record conditioned fear and sensorimotor gating ability. Forty 
adult male rats were randomly assigned to five groups (n = 8/group): the CS+, the CS−, the 
Light-only, the Shock-only, or no-Light-Shock group. They only differed on the fear 
conditioning day. The overall experimental procedure consisted of the following four phases: 
Baseline tests of startle and PPI, Fear conditioning, Post-conditioning retests of startle and 
PPI, and Fear-potentiated startle and PPI test (Fig. 1).
Baseline tests of startle and PPI (Day 1 and Day 2)—Rats were first habituated to 
the startle chambers for 20 min under 70 dB background noise (Day 0), then they were 
tested for their baseline startle response and PPI daily for 2 days. Each daily session started 
with a 5-min period acclimatization with 70 dB background noise, followed by four mixed 
trial types: PULSE ALONE trials (105 dB white nose, 40 ms), and three types of 
PREPULSE+PULSE trials (a 20 ms 75, 78, or 82 dB prepulse, followed 100 ms later by the 
PULSE). Each trial type occurred 10 times, and a total of 40 trials occurred in a 
pseudorandom order. At the beginning and end of each session, 4 additional PULSE 
ALONE trials were added to examine startle response habituation and they were not used in 
the calculation of PPI. The inter-trial interval ranges from 25 to 35 s (average 30 s). Startle 
magnitude was defined as the maximum force (measured in Newtons) applied by the rat to 
the startle apparatus recorded over a period of 100 ms beginning at the onset of the PULSE 
stimulus.
Percent prepulse inhibition (% PPI) for each acoustic prepulse trial type was calculated 
using the standard PPI equation: [100−(mean PREPULSE+PULSE response/mean PULSE 
response) × 100]. Percent startle habituation (% habituation) was calculated as: 100− 
(averaged startle magnitude for the final 4 PULSE trials/averaged startle magnitude for the 
first 4 PULSE trials) × 100, i.e., the higher the % value, the greater the habituation.
Fear conditioning (Day 3)—Fear conditioning session was conducted in the same 
cabinets where the rats were tested for the startle and PPI, with the same background noise 
(70 dB). Rats in the CS+ group received 10 CS (3.7 s light) – US (0.6 mA, 0.5 s footshock) 
pairing trials, with an average inter-trial interval of 4 min (3 min to 5 min). The CS− group 
received the same number of light and footshock trials, but they were presented randomly 
and never overlapped. The Light-only group received 10 light presentations with no shock, 
while the Shock-only group received 10 footshocks but no light. Finally, the no-Light-Shock 
group was not exposed to any light or footshock.
Post-conditioning retests of startle and PPI (Day 4 and Day 5)—Rats were tested 
again for startle response and PPI using the same procedure as used in the baseline tests for 
2 days. Changes from the baseline tests could potentially reveal the impact of contextual fear 
on startle response and PPI.
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Fear-potentiated startle and PPI test (Day 6)—The test procedure was similar to that 
used in the baseline startle response and PPI test with the exception that the CS (3.2 s) was 
presented in 40 trials (10 PULSE ALONE trials and 10 trials of each PREPULSE+PULSE 
type), while in another 40 trials, no CS was presented. In the CS presented trials, the CS was 
initiated 3.2 s before the onset of the PULSE (40 ms), and co-terminated with the PULSE. 
These 80 trials were intermixed and presented in a random fashion, with an average inter-
trial interval of 30 s. The magnitude of startle response (mean of the 10 PULSE ALONE 
trials) and PPI under both CS and No CS conditions were recorded and calculated 
separately.
2.5 Experiment 2: Pharmacological validation of an integrated fear-potentiated startle and 
prepulse inhibition paradigm
This experiment validated this integrated fear-potentiated startle and prepulse inhibition 
paradigm using pharmacological tools. Thirty adult male SD rats were randomly assigned to 
one of the three groups (n = 10/group): Diazepam (2.0 mg/kg), PCP (1.5 mg/kg), and vehicle 
control (5 on 30% DMF and 5 on 0.9% saline). Rats were first handled for five consective 
days. On the last day of handling, they were injected with either 30% DMF (i.p.) or saline 
(s.c.) based on the solvent that they were given on the test to habituate them to the injection 
procedure. The FPS and PPI procedure was identical to that of Experiment 1, consisting of 
the 4 phases: Baseline tests of startle and PPI, Fear conditioning, Post-conditioning retests of 
startle and PPI, and Fear-potentiated startle and PPI test. Diazepam, PCP or vehicle was 
administered 10 min before the final FPS and PPI test.
Eight days after the test, all rats were tested in the EPM (averaged light intensity for open 
arms: 83 lux; averaged light intensity for close arms: 9 lux) in a separate room. On the test 
day, rats were first brought to the experimental room and habituated to the test environment 
for at least 30 min. Each rat was injected with diazepam, PCP, or vehicle first. Thirty min 
later, they were placed in the center of the maze facing an open arm and allowed to freely 
explore the maze for 5 min. All experimental sessions were recorded by a video camera. 
Time in open arm and close arm was obtained using Viewer II (Biobserve), and percent (% 
open arm time) in open arms was calculated as: 100 × time spent in the open arms/total time. 
An entry to an arm was defined as the all four feet entering the arm and % open arm entry 
was calculated as: 100 × number of entries to the open arms/number of entries to all arms. 
Three rats from the diazepam group fell off the maze, their data were excluded for further 
analysis.
2.6 Statistical analysis
All data are expressed as mean ± SEM. Percent PPI data on different test days are presented 
separately. Percent startle habituation on the two baseline test days before conditioning and 
two days after conditioning are combined and averaged and presented separately from those 
on the final test day. In all experiments, there were highly signficiant prepulse intensity 
effects (75, 78 and 82 dB Prepulse levels). For clarity, only averaged % PPI is reported in the 
text. Averaged % PPI and the startle response data were analyzed using repeated measures 
ANOVAs with group (CS+, CS−, Light-only, Shock-only, no-Light-Shock) (Experiment 1) 
and drug (PCP, Diazepam, Vehicle) (Experiment 2) as between-group factors, and test day or 
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test condition (CS vs. No CS) as within-subjects factors followed by post hoc Bonferroni 
test. Percent changes of startle magnitude and averaged % PPI between the CS and No CS 
conditions are additionally analyzed using nonparametric tests if normal distrubtion was 
violated. Percent startle habituation was analyzed by one-way ANOVA. For the EPM test, 
one-way ANOVA was conducted on % open arm time and % open arm entries separately. If 
the sphericity assumption was not valid, then Greenhouse-Geisser correction would be used. 
Statistical significance is defined as p <0.05. All data were analyzed using SPSS (v. 22).
3. Results
3.1 Experiment 1: Behavioral validation of an integrated fear-potentiated startle and 
prepulse inhibition paradigm
3.1.1 Baseline startle response and PPI—The five groups did not differ on the 
magnitude of baseline startle response on both days. Repeated measures ANOVA showed no 
significant main effect of day, F(1, 35) = 0.563, p = 0.458, group, F(4, 35) = 1.099, p = 
0.372, nor the day × group interaction, F(4, 35) = 0.227, p = 0.922 (Fig. 2A). The five 
groups also did not show any significant group difference on the averaged PPIs, as the main 
effect of group, F(4, 35) = 0.986, p = 0.428, day, F(1, 35) = 2.141, p = 0.152, and the day × 
group interaction, F(4, 35) = 0.319, p = 0.863 were not significant (Fig. 2B).
3.1.2 Changes in startle and PPI responses from Day 2 (pre-conditioning) to 
Day 4 (post-conditioning)—Comparisons between the startle responses of the five 
groups one day before the fear conditioning (Day 2) and one day after fear conditioning 
(Day 4) were made in an attempt to reveal potential contexutal fear on baseline startle 
response. Repeated measues ANOVA found no significant main effect of group, F(4, 35) = 
1.014, p = 0.413, day, F(1, 35) = 0.801, p = 0.377, or test day × group interaction, F(4, 35) = 
1.226, p = 0.318. The main effect of day was also not significant, p = 0.377 (Fig. 2C). 
Similarly, the five groups were compared for their PPIs one day before conditioning and one 
day after conditioning. Once again, there was no significant main effect of group, F(4, 35) = 
1.141, p = 0.353, day, F(1, 35) = 3.322, p = 0.077, or test day × group interaction, F(4, 35) = 
1.637, p = 0.187 (Fig. 2D).
3.1.3 Fear-potentiated startle and PPI test (Day 6)—On the fear-potentiated startle 
test day, only rats that were subjected to the light-footshock conditioning (the CS+ group) 
showed a higher startle response under the CS (light) condition compared to the No CS 
(dark) condition, indicating that only this group exhibited fear-potentiated startle. Repeated 
measures ANOVA revealed a condition (Light vs. No Light) × group interaction, F(4, 35) = 
3.023, p = 0.031. Paired samples test showed that the CS+ group exhibited a significantly 
higher startle response under the CS condition than under the No CS (dark) condition, p = 
0.004 (Fig. 3A). Other groups did not show any significant effect of condition, all p > 0.289.
Because data of the CS− group under the CS condition were not normally distributed, to 
further determine the effect of CS on startle response, we calculated the percent change of 
startle under the CS condition compared to the no CS condition using the following formula: 
[(startle magnitude under the CS condition - startle magnitude under the No CS condition)/
startle magnitude under the No CS condition] × 100 (see Fig. 3B). We tested group 
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differences using the nonparametric Kruskal-Wallis test. This analysis shows that the five 
groups were still significantly different from each other, p = 0.034. Further pairwise-
comparison shows that only the CS+ group had higher percent increase in startle response 
under the CS condition compared to the other four groups (all p < 0.045, unadjusted sig.). 
We also did the paired-samples t-tests and found that only the CS+ group showed an 
increase of startle magnitude (noted by positive value of percent change of startle magnitude 
compared to zero), t(7) = 3.225, p = 0.014.
Although there was no group difference in PPI under either the CS or No CS condition, PPI 
was significantly lower under the CS (light) condition than under the No CS (dark) 
condition, suggesting that presence of a visual stimulus interfered with attentional process to 
an auditory stimulus. Three-way ANOVA confirmed this observation. There was a main 
effect of CS condition, F(1, 35) = 4.495, p = 0.041, but no main effect of group, F(4, 35) = 
2.345, p = 0.074, or condition × group interaction, F(4, 35) = 2.571, p = 0.055, and the 
observed power was 0.663 (Fig. 3C).
Because the averaged PPI data of the Light group under the No CS condition were not 
normally distributed, in order to determine whether the presence of the CS affected the PPI, 
we calculated the percent change of averaged PPI using this formula: [(averaged PPI under 
the CS condition − averaged PPI under the No CS condition)/averaged PPI under the No CS 
condition] × 100 (Fig. 3D). This transformed dataset from the five groups were normally 
distributed. One-way ANOVA shows the group difference was significant, F(4,35) = 2.842, p 
= 0.039, and that the Light group was different from the CS+ group, p = 0.020. Five separate 
paired-sample t-tests were conducted, and only the Light group showed a decrease of 
averaged PPI, t(7) = −4.256, p = 0.004.
3.1.4 Startle response habituation—There appear to be a lot of individual variances in 
% startle habituation. However, all five groups, as a whole showed a habituation effect (i.e. 
an decrease in averaged startle magnitude from the first 4 trials at the beginning of each 
session to the final 4 trials at the end of each session) and they did not differ from each other 
on the 4 test days prior to and afer fear conditioning (Fig. 4A) (one-way ANOVA, F(4, 35) = 
1.967, p =0.121). The five groups also did not differ on % startle response habituation on the 
CS test day, as one-way ANOVA showed the group effect was not significant, F(4, 35) = 
2.243, p = 0.084, and the observed power was 0.595 (Fig. 4B).
3.2 Experiment 2: Pharmacological validation of an integrated fear-potentiated startle and 
prepulse inhibition paradigm
3.2.1 Baseline startle response and PPI—As expected, the three groups did not differ 
on the magnitude of startle response on both days, as repeated measures ANOVA showed no 
significant main effect of day, F(1, 27) = 0.087, p = 0.770, group, F(2, 27) = 1.410, p = 
0.262, nor the day × group interaction, F(2, 27) = 1.605, p = 0.219 (Fig. 5A). They also did 
not differ on the averaged PPIs, as the main effect of group, F(2, 27) =1.762, p = 0.191, and 
day × group interaction, F(2, 27) = 0.110, p = 0.896 were not significant (Fig. 5B). However, 
the main effect of day was significant, F(1, 27) = 6.671, p = 0.016, showing an improvement 
of PPI over time, a finding consistent with our previous reports [15, 20].
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3.2.2 Changes in startle and PPI responses from Day 2 (pre-conditioning) to 
Day 4 (post-conditioning)—To examine whether fear conditioning altered startle 
response and PPI perfromance, repeated measues ANOVA was used to compare startle and 
PPI on Day 2 and Day 4. On the startle response, no significant main effect of day, F(1, 27) 
= 1.082, p = 0.308, group, F(2, 27) = 2.054, p = 0.148, or test day × group interaction, F(2, 
27) = 0.460, p = 0.636 was found (Fig. 5C). Similarly, for the PPI performance, there was no 
significant main effect of group, F(2, 27) = 3.009, p = 0.066 (the observed power was 
0.535), day, F(1, 27) = 3.040, p = 0.093, nor day × group interaction, F(2, 27) = 0.033, p = 
0.967 (Fig. 5D).
3.2.3 Fear-potentiated startle and PPI test (Day 6)—On the fear-potentiated startle 
test day, while the PCP and control groups all showed enhanced startle response under the 
CS (light) condition relative to the No CS (dark) condition, this fear-potentiated startle was 
abolished by diazepam treatment. A CS condition × group repeated measures ANOVA 
revealed a main effect of CS condition (CS vs. No CS), F(1, 27) = 44.627, p < 0.001, and the 
significant group × CS condition interaction, F(2, 27) = 6.207, p = 0.006, but no main effect 
of group, F(2, 27) = 2.100, p = 0.142. Further comparisons revealed that the PCP and the 
vehicle control groups expressed enhanced startle response under the CS condition in 
comparison to the No CS condition, p < .001, while the diazepam group did not, p = 0.296 
(Fig. 6A).
On the PPI measures, both the diazepam and PCP groups showed lowered PPI compared to 
the control group. Once again, the averaged PPI was lower in the CS trials than in the No CS 
trials. Repeated measures ANOVA found a main effect of group, F(2, 27) = 4.822, p = 0.016, 
and CS condition, F(1, 27) = 8.039, p = 0.009, but no group × condition interaction, F(2, 27) 
= 0.587, p = 0.563. Post hoc analysis revealed that the PCP group had significantly lower 
PPI compared to the control group, p = 0.026. The diazepam group also showed a reduction 
of PPI, p = 0.039 (Fig. 6B).
3.2.4 Startle response habituation—Like what is seen in Experiment 1, large 
individual variances in % startle habituation were observed. The groups were compared on 
the averaged four baseline test startle response hibitation, and they did not differ from each 
other on this measure (Fig. 7A) (F(2, 27) = 0.866, p =0.432). They also did not differ on the 
CS test day (F(2, 27) = 0.332, p = 0.721) (Fig. 7B).
3.2.5 Elevated Plus Maze—To confirm the anxiolytic effect of diazepam, rats were 
tested in the classic EPM test. Diazepam appeared to have increased time spent on the open 
arms. One-way ANOVA showed that the three groups differed on the percent time spent on 
the open arms, F(2, 24) = 5.436, p = 0.011. Post hoc analyses found that the diazepam group 
spent relatively more time in the open arms than the vehicle group and PCP group, p = 0.012 
(vs. PCP group) and p = 0.047 (vs. Control group) (Fig. 8A). Furthermore, the three groups 
also differed on % open arm entries, F(2, 27) = 6.544, p = 0.005, with the diazepam group 
showing higher % open arm entries than the other two groups, p = 0.010 (vs. PCP group) 
and p = 0.017 (vs. Control group). These finding confirmed the anxiolytic effect of diazepam 
(Fig. 8B).
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4. Discussion
Here we introduce a new protocol that successfully and simultaneously records PPI and FPS 
and provides pharmacological validation of such a protocol. Specifically, in Experiment 1, 
we showed that the enhanced startle response under the Light condition relative to the no 
Light condition reflects conditioned fear, as only rats that were subject to the CS-US 
conditioning showed this enhanced startle elicited by Light, but not those who only 
experienced the CS alone, or the US alone, or non-paired CS and US or not experienced the 
CS or US at all. More importantly, all rats displayed PPI and the overall magnitude was no 
different from what have reported in the literature (40–60%) and reported by us [15, 20, 21]. 
Experiment 2 used this paradigm and revealed some known psychotropic effects of 
diazepam and PCP: diazepam suppressed FPS, while PCP selectively disrupted PPI but not 
FPS. The diazepam EPM data were consistent with the effect of diazepam on negative 
emotions (e.g. fear or anxiety). Moreover, this new paradigm reveals a process pertaining to 
an across-modality interference on attentional processing, as PPI was found to be 
significantly lower under the CS (Light) condition than under the No CS (dark) condition. In 
addition, our paradigm reveals a subtle yet significant suppressive effect of diazepam on PPI. 
Overall, this study illustrates the power of an integrated FPS and PPI paradigm in detecting 
multiple psychological processes and their potential interactions. It is useful for screening 
new compounds with multiple psychoactive effects and for the study of neurobiology of 
negative emotions and attention.
One unique aspect of our new paradigm is that its FPS component follows almost the exact 
same procedure as typically employed in a FPS alone experiment [3, 22]. This feature allows 
easy comparison and validation of FPS as measured in this study with that in FPS alone 
studies. First, animals are subject to a Pavlovian fear conditioning procedure involving 10 
pairings of a 3.7 sec light with a 0.5 sec electric footshock of moderate intensity (0.6 mA) 
presented 3.2 sec after the light onset. Three days after conditioning, the animals undergo a 
test in which acoustic startle stimuli are presented during the presentation of the light (CS 
trials) or in the absence of the light (No CS trials) and the differences in startle magnitude 
between CS and No CS trials provide the operational measure for conditioned fear [1, 23]. 
We are confident that FPS measures conditioned fear because only the conditioned group 
(the CS+ group) showed the significant differences in startle magnitude between CS and No 
CS trials. The Light itself did not elicit startle response, and the startle-eliciting stimulus (i.e. 
PULSE) was never paired with a shock. Furthermore, the shock itself or separated Light and 
shock presentation did not cause FPS. Therefore, inclusion of 5 experimental conditions 
allows us to determine unequivocally that the temporally associated light and shock is 
responsible for the elevated startle amplitude in the presence of the light previously paired 
with shock. This feature of our new paradigm ensures an easy comparison of results from 
the present study to those in the literature. Indeed, the revealed suppressive effect of 
diazepam on the expression of FPS is consistent with the known anxiolytic effect of 
diazepam in a variety of behavioral tests of anxiety [24–27]. We recently conducted a 
separate experiment to examine how diazepam administered prior to the fear conditioning 
session would affect the acquisition of conditioned fear as measured in FPS. Our results 
showed that diazepam did not affect neither FPS nor PPI when given 10 min prior to the 
Zhang and Li Page 9
Behav Brain Res. Author manuscript; available in PMC 2017 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
conditioning session (Figure 9), as opposed to the test session (in the present study). 
Together with the present study, these findings suggest that this new paradigm is not only 
capable of detecting anxiolytic effect of a drug, but also useful to identify the specific 
processes that are affected by various pharmacological manipulations.
In both experiments, we observed that averaged PPI was significantly lower under the CS 
(light) condition than under the No CS (dark) condition (Fig. 3B and 6B). We interpreted 
this finding as reflecting an across-modality interference (visual to auditory) on attention to 
sensory processing, as if the presence of a visual stimulus interfered with attentional 
processing of an auditory stimulus. This interference appears in all experimental conditions 
even when the light was not paired with shock or simply appeared for the first time, 
indicating that the main source of this interference comes from attentional modulation of 
auditory sensory processing by a visual stimulus. It is possible that the onset of light might 
disrupt attention (e.g. alerting and/or orienting) to process the prepulse, thus interferes with 
its ability to reduce startle response. Another source, although not apparent, may come from 
the modulation of attention by negative emotion (e.g. conditioned fear) [28]. The light, after 
becoming a CS due to its pairing with shock, may activate a central state of fear. Evidence 
suggests that negative emotion can alter attention [29, 30]. For example, it has been reported 
that PPI is enhanced when the prepulse is emotionally salient rather than neutral stimulus in 
humans [31]. In rats, following the prepulse becoming fear conditioned or fear-extinction 
conditioned, its strength in inhibiting the startle reflex is enhanced, resulting an enhanced 
PPI [32]. These studies suggest that when the prepulse becomes biologically significant, 
more attention resource is directed toward processing its occurrence. The present finding 
that a fear-conditioned stimulus could interfere with PPI provides another example that 
emotional learning (fear conditioning) indeed top-down modulates sensory gating. However, 
we think the impact of this source on PPI is relatively small. This is because we did not 
observe a larger decrease in PPI in the CS+ group than in other groups, which should be 
expected if the main source of Light impact is from conditioned fear. Regardless of the exact 
sources, the mere observation of this across-modality interference on PPI performance is an 
interesting finding. We are not aware of any similar finding in the literature. If replicated and 
confirmed in the future studies, it could be used as a behavioral measure of conflict in 
sensory processing.
In the present study, we also compared changes in startle magnitude and PPI before and after 
fear conditioning in an attempt to reveal the potential impact of putative contextual fear on 
startle response and PPI. We hypothesized that rats might develop a contextual fear to the 
testing environment, in addition to acquiring a conditioned fear to the CS. If there were a 
contextual fear, we would expect to see higher startle responses one day after the 
conditioning relative to one day before. Our results did not support this hypothesis. The lack 
of contextual fear might be due to the lack of salient environmental cues and loss of novelty 
of the fear conditioning environment. In our studies, rats were habituated to the environment 
for 3 days. The startle chamber does not contain any distinct sensory cues. On the 
conditioning day, the CS was presented in this familiar environment. Previous work has 
shown that under this testing procedure, the animal is better able to learn the CS-US 
association because the context is not as accurate a predictor of shock as the CS[33] and 
conditioning to the explicit cues is easier than conditioning to the experimental context [34]. 
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The second reason that we failed to observe contextual fear might be that our startle 
response is not as sensitive as freezing in detecting contextual fear.
The disruptive effect of PCP on PPI and the decreasing effect of diazepam on FPS are two 
well documented findings in the literature [15, 20, 26, 35–37]. The fact that we observed 
both effects in our new paradigm suggests that this paradigm is just as good as the PPI alone 
or FPS alone paradigm. The PPI-disruptive effect of diazepam was a little bit surprising, 
given that benzodiazepines are not known for their effect on PPI [38]. However, such a 
finding does exist. For example, Depoortere et al. (1997) examined three doses of diazepam 
(1.0, 3.0 and 10.0 mg/kg) and found that diazepam at the highest dose reduced PPI [39]. 
Silva et al. (2005) also reported a similar finding with 4.0 mg/kg diazepam [40]. Other 
studies in the literature either report that diazepam does not affect PPI [41] or improve it 
[42]. Taken together, it appears that diazepam’s effect on PPI may depend on specific 
experimental conditions (e.g. number of trials, intensity of prepulse, animal strains, etc.) and 
remains inconclusive. Therefore, caution needs to be exercised when the PPI effect of 
diazepam is evaluated.
Our new integrated FPS and PPI testing protocol has important applications for behavioral 
neuroscience and pharmacological research. For basic behavioral neuroscience research, it 
has an advantage in the study of various psychological processes involved in Pavlovian 
conditioning (e.g. acquisition, consolidation, reconsolidation, retrieval, etc.) and attention 
regulation of sensory processing, as well as their interactions. This paradigm could also be 
easily used to study experimental factors that influence FPS and PPI and evaluate animal 
models of neuropsychiatric disorders with a fear and attention deficit component (e.g. 
posttraumatic stress disorder, schizophrenia, etc.). One other use of this paradigm is to 
explore effective behavioral techniques that could suppress fear and improve attention 
function. This work would expand our knowledge about the factors that control human fear 
and attention, and may help develop more effective techniques for the suppression of 
pathological fear in humans and improvement of cognition. From the neurobiological 
perspective, this integrated paradigm could be used to identify neurochemical and 
neuroanatomical substrates that mediate basal startle, FPS and PPI, as well as their 
interactions. The glutamatergic, dopaminergic and GABAergic neurotransmission in the 
amygdala-striatal network may play an important role in this regard [1, 4, 29, 43]. 
Pharmacologically, our new paradigm could be used to quickly screen chemical compounds 
with dual anxiolytic and cognitive-improving properties and identify relevant neurochemical 
mechanisms [44]. It could also be used to evaluate potential side effects of a drug on 
emotion regulation and attention. Diazepam is an example: although it suppresses 
conditioned fear, it causes a slight PPI deficit.
In conclusion, the present study shows that our integrated paradigm is capable of studying 
FPS and PPI simultaneously. In addition, it could be used to study an across-modality 
interference of PPI. This new paradigm is also capable of distinguishing different classes of 
psychoactive drugs and could be useful for the examination of potential interactions between 
multiple psychological processes, to identify the common neural substrates and to screen 
new drugs with multiple psychoactive effects.
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Highlights
1. Fear-potentiated startle and prepulse inhibition were shown in a single 
paradigm.
2. Prepulse inhibition of acoustic startle was lower in the presence of a light.
3. This integrated paradigm was validated by diazepam and phencyclidine.
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Fig. 1. 
A schematic depiction of the experimental procedures used in Experiments 1 and 2.
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Fig. 2. 
Baseline startle response and PPI. The basal startle response (A) and averaged PPI (B) 
before conditioning (Day 1 and Day 2) did not differ among the five experimental groups. 
Comparison of the startle response (C) and averaged PPI (D) one day before (Day 2) and 
one day after conditioning (Day 4) also did not reveal any group difference.
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Fig. 3. 
The fear-potentiated startle and PPI tested under the CS (Light) and no CS (dark, no Light) 
condition. The fear-potentiated startle (i.e., a significant difference in startle response under 
the CS versus no CS condition) (A & B) was observed only in the CS+ group. Averaged PPI 
was higher under the No CS condition than under the CS condition (C). However, the 
percent change of averaged PPI was only shown significant in the Light group (D). #p < 0.05 
in comparison to the CS+ group. *p < 0.05; **p < 0.01.
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Fig. 4. 
Habituation of startle response (percent change from the last 4 PULSE trials to the first 4 
PULSE trials). The averaged percent change of startle magnitude from the four baseline tests 
did not differ among the five groups (A). They also did not differ on this measure the final 
fear-potentiated startle and PPI test (B).
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Fig. 5. 
Baseline startle response and PPI. The basal startle response (A) and averaged PPI (B) 
before conditioning (Day 1 and Day 2) did not differ among the three experimental groups. 
Comparison of the startle response (C) and averaged PPI (D) one day before (Day 2) and 
one day after conditioning (Day 4) also did not reveal any group difference.
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Fig. 6. 
The fear-potentiated startle and PPI tested under the CS (Light) and no CS (dark, no Light) 
condition. The fear-potentiated startle (i.e., a significant difference in startle response under 
the CS versus no CS condition) (A) was observed in the PCP and control groups, but not in 
the diazepam group. Averaged PPI was significantly lower in the PCP and diazepam groups 
compared to the control group. *p < 0.05, **p < 0.01, ***p <0.001.
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Fig. 7. 
Habituation of startle response (percent change from the last 4 PULSE trials to the first 4 
PULSE trials). The averaged percent change of startle magnitude from the four baseline tests 
did not differ among the three groups (A). They also did not differ on this measure the final 
fear-potentiated startle and PPI test (B).
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Fig. 8. 
Percentage of time spent in the open arms (A) and percentage of open arm entries (B) by the 
three drug groups. Only the diazepam group showed a significant increase in the percentage 
of time spent in the open arms, * p < 0.05.
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Fig. 9. 
The fear-potentiated startle and PPI tested under the CS (Light) and no CS (dark, no Light) 
condition. Diazepam (2.0 mg/kg, i.p.) was administered 10 min prior to the fear conditioning 
session. The fear-potentiated startle (A) and averaged PPI (B) were not affected by diazepam 
treatment. **p < 0.01, ***p <0.001.
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